amrubicin April 12, 2017 amrubicin Trade Name Orphan Indication Small cell lung cancer USA Market Approval USA USA Designation Date 2008-03-10 00:00:00 Sponsor Celgene Corporation;9900 W. 109th Street, Suite 300;Overland Park, Kansas, 66210
